Aptar Pharma has launched a new twistable dry powder inhaler (DPI) which it says is a “cost effective” way to improve drug delivery as well as patient compliance.
Bang & Olufsen Medicom has unveiled a new disposal
breath-actuated inhaler which uses a reservoir technology that
reduces the daily cost of pulmonary drug delivery.
The US Food and Drug Administration (FDA) has urged the pharma
industry to develop preservative-free nasal sprays, however, there
is currently a vacuum of manufacturers that can fulfil such a
requirement.
MAP Pharmaceuticals has awarded the manufacturing of the
metered-dose components of its new inhaler devices to Xemplar, who
is one of the few contract manufacturers in the world that can take
on such a challenge and is now upping...
3M has teamed up with MicroDose Technologies to market a new
metered dose inhaler that should be cheap to produce and deliver a
broad range of compounds.